Palvella Therapeutics Appoints New Market Access Leader

Palvella Therapeutics has bolstered its executive team with the appointment of Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services. McDonough brings extensive experience in the rare disease sector, previously holding a key role at Krystal Biotech. Her expertise is expected to be crucial in navigating market access challenges and enhancing patient services for Palvella's pipeline. This strategic hire underscores the company's commitment to ensuring patient access to its innovative therapies.